Here we report the direct comparison of a conventional batch mode synthesis of Meclinertant (SR48692, 1), a neurotensin receptor-1 antagonist, with its machine-assisted flow chemistry alternative. By using these enabling tools, combined with solid-supported reagents and scavengers, many process advantages were observed. Care, however, must be taken not to convert these techniques into expensive solutions to problems that do not exist.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/chem.201300696 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!